Assessing the impact of migraine on benign paroxysmal positional vertigo symptoms and recovery.
BPPV
Benign paroxysmal positional vertigo
Dizziness
Migraine
Vertigo
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
02 May 2024
02 May 2024
Historique:
received:
08
10
2023
accepted:
18
03
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
2
5
2024
Statut:
epublish
Résumé
During episodes of benign paroxysmal positional vertigo (BPPV), individuals with migraine, compared with individuals without migraine, may experience more severe vestibular symptoms because of their hyperexcitable brain structures, more adverse effects on quality of life, and worse recovery processes from BPPV. All patients with BPPV were assigned to the migraine group (MG, n = 64) and without migraine group (BPPV w/o MG, n = 64) and completed the Vertigo Symptom Scale (VSS), Vertigo Dizziness Imbalance Symptom Scale (VDI-SS), VDI Health-Related Quality of Life Scale (VDI-HRQoLS), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) at the time of BPPV diagnosis (baseline) and on the one-month follow-up. Headache Impact Test-6 and Migraine Disability Assessment Scale were used for an assessment of headache. Motion sickness was evaluated based on the statement of each patient as present or absent. Compared with the BPPV w/o MG, the MG had higher VSS scores at baseline [19.5 (10.7) vs. 11.3 (8.5); p < 0.001] and on one-month follow-up [10.9 (9.3) vs. 2.2 (2.7), p < 0.001]; experienced more severe dizziness and imbalance symptoms based on the VDI-SS at baseline (61.9% vs. 77.3%; p < 0.001) and after one month (78.9% vs. 93.7%, p < 0.001); and more significantly impaired quality of life according to the VDI-HRQoLS at baseline (77.4% vs. 91.8%, p < 0.001) and after one month (86.3% vs. 97.6%, p < 0.001). On the one-month follow-up, the subgroups of patients with moderate and severe scores of the BAI were higher in the MG (39.2%, n = 24) than in the BPPV w/o MG (21.8%, n = 14) and the number of patients who had normal scores of the BDI was lower in the MG than in the BPPV w/o MG (67.1% vs. 87.5%, p = 0.038). Clinicians are advised to inquire about migraine when evaluating patients with BPPV because it may lead to more intricate and severe clinical presentation. Further studies will be elaborated the genuine nature of the causal relationship between migraine and BPPV.
Sections du résumé
BACKGROUND
BACKGROUND
During episodes of benign paroxysmal positional vertigo (BPPV), individuals with migraine, compared with individuals without migraine, may experience more severe vestibular symptoms because of their hyperexcitable brain structures, more adverse effects on quality of life, and worse recovery processes from BPPV.
METHODS
METHODS
All patients with BPPV were assigned to the migraine group (MG, n = 64) and without migraine group (BPPV w/o MG, n = 64) and completed the Vertigo Symptom Scale (VSS), Vertigo Dizziness Imbalance Symptom Scale (VDI-SS), VDI Health-Related Quality of Life Scale (VDI-HRQoLS), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI) at the time of BPPV diagnosis (baseline) and on the one-month follow-up. Headache Impact Test-6 and Migraine Disability Assessment Scale were used for an assessment of headache. Motion sickness was evaluated based on the statement of each patient as present or absent.
RESULTS
RESULTS
Compared with the BPPV w/o MG, the MG had higher VSS scores at baseline [19.5 (10.7) vs. 11.3 (8.5); p < 0.001] and on one-month follow-up [10.9 (9.3) vs. 2.2 (2.7), p < 0.001]; experienced more severe dizziness and imbalance symptoms based on the VDI-SS at baseline (61.9% vs. 77.3%; p < 0.001) and after one month (78.9% vs. 93.7%, p < 0.001); and more significantly impaired quality of life according to the VDI-HRQoLS at baseline (77.4% vs. 91.8%, p < 0.001) and after one month (86.3% vs. 97.6%, p < 0.001). On the one-month follow-up, the subgroups of patients with moderate and severe scores of the BAI were higher in the MG (39.2%, n = 24) than in the BPPV w/o MG (21.8%, n = 14) and the number of patients who had normal scores of the BDI was lower in the MG than in the BPPV w/o MG (67.1% vs. 87.5%, p = 0.038).
CONCLUSION
CONCLUSIONS
Clinicians are advised to inquire about migraine when evaluating patients with BPPV because it may lead to more intricate and severe clinical presentation. Further studies will be elaborated the genuine nature of the causal relationship between migraine and BPPV.
Identifiants
pubmed: 38698310
doi: 10.1186/s12883-024-03606-2
pii: 10.1186/s12883-024-03606-2
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148Informations de copyright
© 2024. The Author(s).
Références
Group GBDNDC. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16(11):877–897.
Sprenger T, Borsook D. Migraine changes the brain: neuroimaging makes its mark. Curr Opin Neurol. 2012;25(3):252–62.
pubmed: 22487570
pmcid: 3380341
doi: 10.1097/WCO.0b013e3283532ca3
Coppola G, Chen W-T. Neurophysiology of the Migraine Brain: Springer; 2021.
Schwedt TJ, Chiang CC, Chong CD, Dodick DW. Functional MRI of migraine. Lancet Neurol. 2015;14(1):81–91.
pubmed: 25496899
doi: 10.1016/S1474-4422(14)70193-0
Denuelle M, Boulloche N, Payoux P, Fabre N, Trotter Y, Geraud G. A PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76(3):213–8.
pubmed: 21148120
doi: 10.1212/WNL.0b013e3182074a57
Boulloche N, Denuelle M, Payoux P, Fabre N, Trotter Y, Geraud G. Photophobia in migraine: an interictal PET study of cortical hyperexcitability and its modulation by pain. J Neurol Neurosurg Psychiatry. 2010;81(9):978–84.
pubmed: 20595138
doi: 10.1136/jnnp.2009.190223
Borsook D, Burstein R. The enigma of the dorsolateral pons as a migraine generator. Cephalalgia. 2012;32(11):803–12.
pubmed: 22798640
pmcid: 3711518
doi: 10.1177/0333102412453952
Cozma S, Ghiciuc CM, Damian L, Pasquali V, Saponaro A, Lupusoru EC, et al. Distinct activation of the sympathetic adreno-medullar system and hypothalamus pituitary adrenal axis following the caloric vestibular test in healthy subjects. PLoS ONE. 2018;13(3):e0193963.
pubmed: 29509800
pmcid: 5839583
doi: 10.1371/journal.pone.0193963
Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci. 2015;35(17):6619–29.
pubmed: 25926442
pmcid: 4412887
doi: 10.1523/JNEUROSCI.0373-15.2015
Saman Y, Bamiou DE, Gleeson M, Dutia MB. Interactions between stress and vestibular compensation - a review. Front Neurol. 2012;3:116.
pubmed: 22866048
pmcid: 3406321
doi: 10.3389/fneur.2012.00116
Do TP, Hougaard A, Dussor G, Brennan KC, Amin FM. Migraine attacks are of peripheral origin: the debate goes on. J Headache Pain. 2023;24(1):3.
pubmed: 36627561
pmcid: 9830833
doi: 10.1186/s10194-022-01538-1
von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D, et al. Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res. 2015;25(3–4):105–17.
doi: 10.3233/VES-150553
Chu CH, Liu CJ, Lin LY, Chen TJ, Wang SJ. Migraine is associated with an increased risk for benign paroxysmal positional vertigo: a nationwide population-based study. J Headache Pain. 2015;16:62.
pubmed: 26141381
pmcid: 4491067
doi: 10.1186/s10194-015-0547-z
Lempert T, Leopold M, von Brevern M, Neuhauser H. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109(12 Pt 1):1176.
pubmed: 11130835
Uneri A. Migraine and benign paroxysmal positional vertigo: an outcome study of 476 patients. Ear Nose Throat J. 2004;83(12):814–5.
pubmed: 15724736
doi: 10.1177/014556130408301211
Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain. 1984;107(Pt 4):1123–42.
pubmed: 6334543
doi: 10.1093/brain/107.4.1123
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211.
Yanik B, Kulcu DG, Kurtais Y, Boynukalin S, Kurtarah H, Gokmen D. The reliability and validity of the vertigo symptom scale and the vertigo dizziness imbalance questionnaires in a turkish patient population with benign paroxysmal positional vertigo. J Vestib Res. 2008;18(2–3):159–70.
pubmed: 19126986
doi: 10.3233/VES-2008-182-309
Yardley L, Masson E, Verschuur C, Haacke N, Luxon L. Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale. J Psychosom Res. 1992;36(8):731–41.
pubmed: 1432863
doi: 10.1016/0022-3999(92)90131-K
Dikmen PY, Bozdag M, Gunes M, Kosak S, Tasdelen B, Uluduz D, et al. Reliability and validity of Turkish Version of Headache Impact Test (HIT-6) in patients with migraine. Noro Psikiyatr Ars. 2021;58(4):300–7.
pubmed: 34924791
Bayliss MS, Dewey JE, Dunlap I, Batenhorst AS, Cady R, Diamond ML, et al. A study of the feasibility of Internet administration of a computerized health survey: the headache impact test (HIT). Qual Life Res. 2003;12(8):953–61.
pubmed: 14651414
doi: 10.1023/A:1026167214355
Ertas M, Siva A, Dalkara T, Uzuner N, Dora B, Inan L, et al. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2004;44(8):786–93.
pubmed: 15330825
doi: 10.1111/j.1526-4610.2004.04146.x
Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88(1):41–52.
pubmed: 11098098
doi: 10.1016/S0304-3959(00)00305-5
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–7.
pubmed: 3204199
doi: 10.1037/0022-006X.56.6.893
Ulusoy M, Sahin NH, Erkmen H. Turkish version of the beck anxiety inventory: psychometric properties. J Cogn Psychother. 1998;12(2):163.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
pubmed: 13688369
doi: 10.1001/archpsyc.1961.01710120031004
Kapci EG, Uslu R, Turkcapar H, Karaoglan A. Beck Depression Inventory II: evaluation of the psychometric properties and cut-off points in a Turkish adult population. Depress Anxiety. 2008;25(10):E104–10.
pubmed: 17876817
doi: 10.1002/da.20371
Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the International classification of vestibular disorders. Neurol Clin. 2015;33(3):541–50 (vii).
pubmed: 26231270
doi: 10.1016/j.ncl.2015.04.010
Huang TC, Wang SJ, Kheradmand A. Vestibular migraine: an update on current understanding and future directions. Cephalalgia. 2020;40(1):107–21.
pubmed: 31394919
doi: 10.1177/0333102419869317
Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41.
pubmed: 11222783
doi: 10.1212/WNL.56.4.436
Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol Rhinol Laryngol. 2000;109(4):377–80.
pubmed: 10778892
doi: 10.1177/000348940010900407
Hilton DB, Luryi AL, Bojrab DI, Babu SC, Hong RS, Bojrab DI 2nd, et al. Comparison of associated comorbid conditions in patients with benign paroxysmal positional vertigo with or without migraine history: a large single institution study. Am J Otolaryngol. 2020;41(6):102650.
pubmed: 32702572
doi: 10.1016/j.amjoto.2020.102650
Faralli M, Cipriani L, Del Zompo MR, Panichi R, Calzolaro L, Ricci G. Benign paroxysmal positional vertigo and migraine: analysis of 186 cases. B-ENT. 2014;10(2):133–9.
pubmed: 25090812
von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007;78(7):710–5.
doi: 10.1136/jnnp.2006.100420
Zhu CT, Zhao XQ, Ju Y, Wang Y, Chen MM, Cui Y. Clinical characteristics and risk factors for the recurrence of benign paroxysmal positional vertigo. Front Neurol. 2019;10:1190.
pubmed: 31798518
pmcid: 6863975
doi: 10.3389/fneur.2019.01190
Andersson H, Jablonski GE, Nordahl SHG, Nordfalk K, Helseth E, Martens C, et al. The risk of benign paroxysmal positional vertigo after head trauma. Laryngoscope. 2022;132(2):443–8.
pubmed: 34487348
doi: 10.1002/lary.29851
Lee SH, Kim JS. Benign paroxysmal positional vertigo. J Clin Neurol. 2010;6(2):51–63.
pubmed: 20607044
pmcid: 2895225
doi: 10.3988/jcn.2010.6.2.51
Perez P, Franco V, Cuesta P, Aldama P, Alvarez MJ, Mendez JC. Recurrence of benign paroxysmal positional vertigo. Otol Neurotol. 2012;33(3):437–43.
pubmed: 22388730
doi: 10.1097/MAO.0b013e3182487f78
Lopez-Escamez JA, Gamiz MJ, Fernandez-Perez A, Gomez-Finana M. Long-term outcome and health-related quality of life in benign paroxysmal positional vertigo. Eur Arch Otorhinolaryngol. 2005;262(6):507–11.
pubmed: 15942805
doi: 10.1007/s00405-004-0841-x
Luryi AL, Lawrence J, Bojrab DI, LaRouere M, Babu S, Zappia J, et al. Recurrence in benign paroxysmal positional vertigo: a large single-institution study. Otol Neurotol. 2018;39(5):622–7.
pubmed: 29649052
doi: 10.1097/MAO.0000000000001800
Gedik-Soyuyuce O, Yalinay-Dikmen P, Korkut N. The effect of migraine and motion sickness on symptoms evoked by the caloric vestibular test. J Vestib Res. 2022;32(2):135–44.
pubmed: 34602507
doi: 10.3233/VES-210046
Teggi R, Colombo B, Albera R, Asprella Libonati G, Balzanelli C, Batuecas Caletrio A, et al. Clinical features, familial history, and migraine precursors in patients with definite vestibular migraine: the VM-phenotypes projects. Headache. 2018;58(4):534–44.
pubmed: 29205326
doi: 10.1111/head.13240
Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014;137(Pt 1):232–41.
pubmed: 24277718
doi: 10.1093/brain/awt320
Dodick DW. Migraine Lancet. 2018;391(10127):1315–30.
pubmed: 29523342
doi: 10.1016/S0140-6736(18)30478-1
Carvalho GF, Vianna-Bell FH, Florencio LL, Pinheiro CF, Dach F, Bigal ME, et al. Presence of vestibular symptoms and related disability in migraine with and without aura and chronic migraine. Cephalalgia. 2019;39(1):29–37.
pubmed: 29635938
doi: 10.1177/0333102418769948
Bruss D, Abouzari M, Sarna B, Goshtasbi K, Lee A, Birkenbeuel J, et al. Migraine features in patients with recurrent benign paroxysmal positional vertigo. Otol Neurotol. 2021;42(3):461–5.
pubmed: 33306663
pmcid: 8423124
doi: 10.1097/MAO.0000000000002976
Minen MT, Begasse De Dhaem O, Kroon Van diest A, Powers S, Schwedt TJ, Lipton R, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87(7):741–9.
pubmed: 26733600
doi: 10.1136/jnnp-2015-312233
Ozcelik P, Kocoglu K, Ozturk V, Keskinoglu P, Akdal G. Characteristic differences between vestibular migraine and migraine only patients. J Neurol. 2022;269(1):336–41.
pubmed: 34109480
doi: 10.1007/s00415-021-10636-0
von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74.
Beh SC, Masrour S, Smith SV, Friedman DI. The Spectrum of vestibular migraine: clinical features, triggers, and examination findings. Headache. 2019;59(5):727–40.
pubmed: 30737783
doi: 10.1111/head.13484